S

Sky Ventures

12 employees

Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in investing in outstanding product-focused

Investor insights

Sectors invested in

Biotechnology38
Health Care37
Medical25
Pharmaceutical18
Therapeutics6
Genetics6
Biopharma5
Hospital5
Health Diagnostics5
Information Technology4
Life Science4
biopharmaceutical4
Antibiotics4
antibiotic resistance4
multidrug-resistant infections4
Gram-negative antibiotics4
bacterial resistance4
inhalation technology and neurology and device delivery systems3
diabetes treatment3
immunotherapy3

Funding rounds participated in

$26M sweet spot round size

Most of their 68 investments are in rounds between $16M and $37M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Finance
Venture Capital

Date founded

1997

Investments made

S

Sutro Biopharma, Inc. raised $85M on July 26, 2018

Investors: Nexthera Capital, Tekla Capital Management, Samsara BioCapital, Surveyor Capital, Vida Ventures, LLC, SV Life Sciences, Lilly Ventures and Sky Ventures

D

Dicerna Pharmaceuticals, Inc. raised $70M on March 30, 2017

Investors: RA Capital Management, L.P., Domain Associates and Sky Ventures

S

SI-BONE raised $26M on June 17, 2016

Investors: Montreux Equity Partners, OrbiMed Advisors, Redline Capital and Sky Ventures

S

SI-BONE raised $21M on May 26, 2015

Investors: Montreux Equity Partners, Redline Capital, OrbiMed Advisors and Sky Ventures

U

Undisclosed raised $45M on May 16, 2014

Investors: Devon Park Bioventures, TVM Life Science Management Inc, MPM Capital, Prism Venture Partners, Inbio Ventures, Intersouth Partners and Sky Ventures

S

SI-BONE raised $33M on April 28, 2014

Investors: Montreux Equity Partners, Novo Holdings, OrbiMed Advisors and Sky Ventures

S

Sutro Biopharma, Inc. raised $26M on December 11, 2013

Investors: SV Life Sciences, Celgene, Alta Partners and Sky Ventures

D

Dicerna Pharmaceuticals, Inc. raised $60M on July 31, 2013

Investors: Domain Associates, Brookside Capital Inc, RA Capital Management, L.P., S.R. One Ltd, Abingworth, Omega Funds and Sky Ventures

U

Undisclosed raised $28M on January 3, 2013

Investors: Aeris Capital AG, Kleiner Perkins, Mohr Davidow Ventures, Safeguard Scientifics and Sky Ventures

S

Sutro Biopharma, Inc. raised $17M on May 8, 2012

Investors: Alta Partners, SV Life Sciences, Lilly Ventures and Sky Ventures

FAQ